middle.news
Why Did Invex Therapeutics Walk Away From Two Neurological Deals?
9:23am on Friday 3rd of October, 2025 AEST
•
Healthcare
Read Story
Why Did Invex Therapeutics Walk Away From Two Neurological Deals?
9:23am on Friday 3rd of October, 2025 AEST
Key Points
Terminated acquisition talks with two neurological treatment companies
Board instability triggered by shareholder requisition notices
Ongoing R&D collaboration on Exenatide for Alzheimer's Disease
Renewed orphan drug designation for Traumatic Brain Injury in Europe
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Invex Therapeutics (ASX:IXC)
OPEN ARTICLE